Summary of Key Points Core Viewpoint - Jiangsu Kangyuan Pharmaceutical Co., Ltd. announced that its major shareholder, Lianyungang Kangber Medical Equipment Co., Ltd., has pledged part of its shares, which may indicate potential liquidity issues or strategic financial maneuvers [1]. Group 1: Shareholding and Pledge Details - Lianyungang Kangber holds 31,870,567 shares of Jiangsu Kangyuan, representing 5.6293% of the total share capital [1]. - After pledging 7 million shares, Kangber has cumulatively pledged 31.87 million shares, which accounts for 99.9982% of its holdings and 5.6292% of the company's total share capital [1]. Group 2: Pledge Usage - The pledged shares are not being used as collateral for major asset restructuring performance compensation or other guarantees [1].
江苏康缘药业股份有限公司 关于持股5%以上股东部分股份质押的公告